Vol 9, No 4 (August 25, 2020): Translational Andrology and Urology

Editorial

How to deal with steroids use in the management of metastatic prostate cancer during pandemic
Michael Baboudjian, Guillaume Ploussard, Shahrokh F. Shariat, Piet Ost, Alberto Briganti, Morgan Roupret, Benjamin Pradere
Translational Andrology and Urology  
2020;
9
(4)
:1546-1549
.

Original Article

Effect of upregulation of DD3 on early detection and prognosis in prostate cancer
Ke Wang, Huishan Zhao, Wenting Wang, Yingqian Zhu, Xuebao Zhang, Jiajia Ma, Haotian Tan, Yulian Zhang, Chunhua Lin
Translational Andrology and Urology  
2020;
9
(4)
:1550-1558
.
Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot- assisted laparoscopic prostatectomy
Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara
Translational Andrology and Urology  
2020;
9
(4)
:1559-1565
.
The clinical application of enhanced recovery after surgery protocol in perioperative period of laparoscopic nephron sparing surgery
Min Tang, Huiyu Dong, Pengfei Shao, Jie Li, Zengjun Wang, Bianjiang Liu
Translational Andrology and Urology  
2020;
9
(4)
:1566-1571
.
Quantitative proteomic analysis of urinary exosomes in kidney stone patients
Qing Wang, Yi Sun, Yuanyuan Yang, Cong Li, Jiaqiao Zhang, Shaogang Wang
Translational Andrology and Urology  
2020;
9
(4)
:1572-1584
.
MicroRNA expression profile in the spinal cord injured rat neurogenic bladder by next-generation sequencing
Zhenhua Shang, Tongwen Ou, Jianjun Xu, Hao Yan, Bo Cui, Qi Wang, Jiangtao Wu, Chunsong Jia, Xin Cui, Jin Li
Translational Andrology and Urology  
2020;
9
(4)
:1585-1602
.
Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEP
Xinglin Chen, Qiuhong Man, Xiyi Wei, Xiaohan Ren, Guangyao Li, Zhongwen Lu, Xu Zhang, Chao Qin
Translational Andrology and Urology  
2020;
9
(4)
:1603-1610
.
Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study
Keyi Wang, Weipu Mao, Heng Shi, Guangchun Wang, Lei Yin, Jinbo Xie, Lap Hong Ian, Hui Zhang, Bo Peng
Translational Andrology and Urology  
2020;
9
(4)
:1611-1629
.
Aberrant integrin αv and α5 expression in prostate adenocarcinomas and bone-metastases is consistent with a bone-colonizing phenotype
Brendan Connell, Pavel Kopach, Wenying Ren, Raghav Joshi, Stephen Naber, Ming Zhou, Paul Mathew
Translational Andrology and Urology  
2020;
9
(4)
:1630-1638
.
The inflammation patterns of different inflammatory cells in histological structures of hyperplasic prostatic tissues
Yisen Meng, Wei Yu, Zhenhua Liu, Muqiu Zhang, Yuke Chen, Shaobo Li, Yu Fan, Shuai Hu, Kai Zhang, Qian Zhang, Jie Jin
Translational Andrology and Urology  
2020;
9
(4)
:1639-1649
.
High PRAS40 mRNA expression and its role in prognosis of clear cell renal cell carcinoma
Jintuo Zhou, Yanting Zhu, Ying Liu, Peiguang Niu, Huajiao Chen, Jie Deng, Daohua Shi
Translational Andrology and Urology  
2020;
9
(4)
:1650-1660
.
Experience of diagnosis and management of metanephric adenoma: retrospectively analysis of 10 cases and a literature review
Lei Zhang, Xian Gao, Ran Li, Kedong Li, Bianjiang Liu, Jie Li, Wei Zhang, Min Tang
Translational Andrology and Urology  
2020;
9
(4)
:1661-1669
.
Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis
Linna Shi, Ruihua Lv, Chen Li, Dong Han, Zhanli Ren, Ge Ren
Translational Andrology and Urology  
2020;
9
(4)
:1670-1677
.
The impact of insurance status on the survival outcomes of patients with renal cell carcinoma
Yan Li, Ming-Xi Zhu, Bing Zhang
Translational Andrology and Urology  
2020;
9
(4)
:1678-1690
.
The efficacy and safety of abiraterone acetate in patients with high-risk prostate cancer: a meta-analysis based on six randomized control trials
Guobin Tan, Zijun Xuan, Zhiqin Li, Shuitong Huang, Guangming Chen, Yonglu Wu, Xianxi Chen, Zhijin Liang, Aiming Wu
Translational Andrology and Urology  
2020;
9
(4)
:1691-1699
.
Vitexin suppresses renal cell carcinoma by regulating mTOR pathways
Yuhong Li, Qinghai Sun, Hui Li, Bin Yang, Meng Wang
Translational Andrology and Urology  
2020;
9
(4)
:1700-1711
.
Berberine alleviates cisplatin-induced acute kidney injury by regulating mitophagy via PINK 1/Parkin pathway
Jieying Qi, Qi Xue, Liuyan Kuang, Lifen Xie, Ren Luo, Xiaoli Nie
Translational Andrology and Urology  
2020;
9
(4)
:1712-1724
.
The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinoma
Guobin Tan, Zijun Xuan, Zhiqin Li, Shuitong Huang, Guangming Chen, Yonglu Wu, Xianxi Chen, Zhijin Liang, Aiming Wu
Translational Andrology and Urology  
2020;
9
(4)
:1725-1734
.
A new method to quantify penile erection hardness: real-time ultrasonic shear wave elastography
Hao Cheng, Zichang Niu, Fengyue Xin, Lin Yang, Litao Ruan
Translational Andrology and Urology  
2020;
9
(4)
:1735-1742
.

Review Article

Clinical efficacy and safety of enhanced recovery after surgery for patients treated with radical cystectomy and ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials
Dechao Feng, Shengzhuo Liu, Yiping Lu, Wuran Wei, Ping Han
Translational Andrology and Urology  
2020;
9
(4)
:1743-1753
.
Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
Fei Sun, Vanesa Lucas-Cava, Francisco Miguel Sánchez-Margallo
Translational Andrology and Urology  
2020;
9
(4)
:1754-1768
.

Case Report

Deep vein thrombosis in a nonobstructive azoospermia male taking tamoxifen: a rare case report
Dalin Sun, Baofang Jin, Bin Cai, Weimin Deng
Translational Andrology and Urology  
2020;
9
(4)
:1769-1772
.
Bartholin gland cyst in a transgender male: case report of a rare occurrence
Salome Niggli, Kathrin Bausch, Barbara Mijuskovic, David Garcia Nuñez, Jan Vosshenrich, Dirk Johannes Schaefer, Hans Helge Seifert, Antje Feicke
Translational Andrology and Urology  
2020;
9
(4)
:1773-1777
.

Editorial on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1

An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
John J. Knoedler, Jay D. Raman
Translational Andrology and Urology  
2020;
9
(4)
:1778-1779
.

Original Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1

Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy
Scott Geiger, Neil Kocher, Dan Illinsky, Evanguelos Xylinas, Peter Chang, Lauren Dewey, Andrew A. Wagner, Firas Petros, Surena F. Matin, Conrad Tobert, Chad Tracy, Pierre-Marie Patard, Mathieu Roumiguie, Leonardo Lima Monteiro, Wassim Kassouf, Jay D. Raman
Translational Andrology and Urology  
2020;
9
(4)
:1780-1785
.
Incidence and preoperative predictors for major complications following radical nephroureterectomy
Neil J. Kocher, David Canes, Karim Bensalah, Morgan Roupret, Costas Lallas, Vitaly Margulis, Shahrokh Shariat, Pierre Colin, Surena Matin, Chad Tracy, Evanguelos Xylinas, Andrew Wagner, Mathieu Roumiguie, Wassim Kassouf, Tobias Klatte, Jay D. Raman
Translational Andrology and Urology  
2020;
9
(4)
:1786-1793
.

Review Article on Upper-Tract Urothelial Carcinoma: Current State and Future Directions1

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
Firas G. Petros
Translational Andrology and Urology  
2020;
9
(4)
:1794-1798
.
Risk stratification for upper tract urinary carcinoma
Daniel Benamran, Thomas Seisen, Elias Naoum, Christophe Vaessen, Jérome Parra, Pierre Mozer, Shahrokh F. Shariat, Morgan Rouprêt
Translational Andrology and Urology  
2020;
9
(4)
:1799-1808
.
Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
Katherine E. Smentkowski, Demetrius H. Bagley, Scott G. Hubosky
Translational Andrology and Urology  
2020;
9
(4)
:1809-1814
.
Endoscopic management of upper tract urothelial carcinoma—tips and tricks
Asaf Shvero, Dorit E. Zilberman, Zohar A. Dotan, Maneham Laufer, Eddie Fridman, Harry Winkler, Nir Kleinmann
Translational Andrology and Urology  
2020;
9
(4)
:1815-1820
.
Outcomes of endoscopic management of upper tract urothelial carcinoma
John J. Knoedler
Translational Andrology and Urology  
2020;
9
(4)
:1821-1830
.
Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
Meredith Metcalf, Phillip M. Pierorazio
Translational Andrology and Urology  
2020;
9
(4)
:1831-1840
.
Oncologic outcomes of radical nephroureterectomy (RNU)
Alexander P. Kenigsberg, Xiaosong Meng, Rashed Ghandour, Vitaly Margulis
Translational Andrology and Urology  
2020;
9
(4)
:1841-1852
.
Perioperative complications and adverse sequelae of radical nephroureterectomy
Alison Levy, David Canes
Translational Andrology and Urology  
2020;
9
(4)
:1853-1859
.
The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
Michael E. Goltzman, Augustyna Gogoj, Benjamin T. Ristau
Translational Andrology and Urology  
2020;
9
(4)
:1860-1867
.
Controversies in management of the bladder cuff at nephroureterectomy
Avery E. Braun, Abhishek Srivastava, Fenizia Maffucci, Alexander Kutikov
Translational Andrology and Urology  
2020;
9
(4)
:1868-1880
.
Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
Matthew G. Kaag
Translational Andrology and Urology  
2020;
9
(4)
:1881-1890
.
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
Peter E. Lonergan, Sima P. Porten
Translational Andrology and Urology  
2020;
9
(4)
:1891-1896
.

Disclosure:

1. The series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. John J. Knoedler and Jay D. Raman served as the unpaid Guest Editors for the series.